Neuron-on-Chip with integrated microelectrodes for research into neurological diseases
CompanyNETRI, Lyon, France
NETRI's NeuroFluidics MEA line was developed in cooperation with Axion Biosystems and combines organ-on-chip platforms with multi-electrode array technology. This enables the electrophysiological recording of microfluidic experiments. The DuaLink MEA and TriaLink MEA platforms are specifically designed for modelling isolated co-cultures linked via axons and functional activity recording. DuaLink Shift MEA enables synaptic isolation and functional activity recording. This allows the individual cell cultures to be modelled and evaluated independently of one another. The product line is based on specially developed cell culture plates (NeoBento), which are available with 16 chips (and 768 electrodes) or 8 chips (and 384 electrodes). The platforms are compatible with common standard models for additional (liquid) treatments or imaging procedures. The neuron-on-chip models are suitable for carrying out (high-throughput) screenings of certain active substances and can help to improve the research and drug treatment of neurological diseases such as Alzheimer's or peripheral neuropathic pain.
NeuroFluidics™ MEA Line
contact@netri.com
Added on: 08-22-2023
[1] https://netri.com/netri-devices/products/neurofluidics-mea-line/[2] https://netri.com/netri-launches-neurofluidics-mea-new-line/
